国产亚洲欧美日韩俺去了,人妻无码久久精品,亚洲人成影院在线观看,亚洲AV永久无码精品表情包

上海非利加實(shí)業(yè)有限公司Logo

熱門(mén)詞: 進(jìn)口電動(dòng)溫度調節閥結構圖|進(jìn)口電動(dòng)溫度調節閥數據表進(jìn)口電動(dòng)高溫調節閥-德國進(jìn)口電動(dòng)高溫法蘭調節閥進(jìn)口電動(dòng)蒸汽調節閥-德國進(jìn)口電動(dòng)蒸汽調節閥

當前位置: 首頁(yè) > 所有品牌 > 近岸科技
近岸科技
近岸科技 近岸科技

上海近岸科技novoprotein   
上海近岸科技有限公司(原欣百諾生物)成立于2004年,是國內首家專(zhuān)門(mén)從事重組蛋白質(zhì)制備工藝開(kāi)發(fā)及生產(chǎn)的高科技企業(yè)。novoprotein 隸屬于上海近岸科技有限公司,提供重組蛋白制備相關(guān)的全套技術(shù)服務(wù),包括:基因合成、表達載體構建、發(fā)酵、純化、質(zhì)量檢測、活性檢測及后期加工處理;我們也生產(chǎn)高品質(zhì)細胞因子、生物活性酶等重組蛋白質(zhì)相關(guān)的試劑產(chǎn)品。


novoprotein 目前成熟的表達體系包括大腸桿菌、酵母、昆蟲(chóng)細胞和哺乳動(dòng)物細胞表達系統,每種表達系統都具有克級以上的制備能力。novoprotein 建立了嚴格的產(chǎn)品質(zhì)控體系及一整套完善的客戶(hù)服務(wù)流程、保密制度以確保為客戶(hù)提供優(yōu)質(zhì)的產(chǎn)品及一流的服務(wù)。

基于公司出色的重組蛋白質(zhì)制備平臺,novoprotein 研發(fā)生產(chǎn)的細胞因子、酶試劑產(chǎn)品憑借其優(yōu)良的品質(zhì)、高性?xún)r(jià)比贏(yíng)得了海外細胞因子及生物試劑銷(xiāo)售商的認可,目前我們已與海外十幾家細胞因子與生物試劑銷(xiāo)售企業(yè)建立了合作關(guān)系。

八年來(lái),我們已完成了千余種重組蛋白質(zhì)的制備,并開(kāi)發(fā)、制備了40多種分子生物學(xué)酶和600余種細胞因子。因為專(zhuān)注所以更專(zhuān)業(yè),我們正在
努力打造重組蛋白質(zhì)制備領(lǐng)域內的旗艦企業(yè)。


SinoBio Biotech (Shanghai) was established in 2004 as an industrial biotechnology initiative from Fudan University. SinoBio understands that protein purification projects are labor intensive, time consuming and riddled with unpredictable outcomes. SinoBio addresses this need for efficient purification services by assembling a team of seasoned biochemists and implementing a streamlined workflow using proprietary chromatographic technologies. The result is SinoBio's highly efficient and scalable pipeline process of recombinant protein purification and production.

Track Record
In four years of commercial operation with 20 scientists, SinoBio has purified nearly 500 recombinant proteins, mg to gram scale, becoming the foremost provider of recombinant protein services to Eastern Asia. SinoBio is also a preferred bulk supplier of 50 enzymes and cytokines to US and European biotechnology reagent vendors. Five drug-related proteins are currently in preclinical trials and one protein is the basis of an IND filing. Scientists in SinoBio Biotech have taken part in 9 major protein drug process development projects, representing one third of biologics in the China protein drug market.

關(guān)于我們客戶(hù)服務(wù)產(chǎn)品分類(lèi)法律聲明